17 results
DEFM14A
ELYM
Eliem Therapeutics Inc
4 Jun 24
Proxy related to merger
8:00am
and regulatory requirements, Leerink Partners has adopted policies and procedures to establish and maintain the independence of its research department … accountant’s independence.
THE ELIEM BOARD UNANIMOUSLY RECOMMENDS A VOTE “FOR” THE RATIFICATION OF THE APPOINTMENT OF THE INDEPENDENT REGISTERED
PREM14A
ELYM
Eliem Therapeutics Inc
17 May 24
Preliminary proxy related to merger
4:36pm
with applicable legal and regulatory requirements, Leerink Partners has adopted policies and procedures to establish and maintain the independence of its research … the principal accountant’s independence.
THE ELIEM BOARD UNANIMOUSLY RECOMMENDS A VOTE “FOR” THE RATIFICATION OF THE APPOINTMENT OF THE INDEPENDENT
DEF 14A
pjshml67
8 Apr 22
Definitive proxy
4:20pm
10-K
j5ivluze
7 Mar 22
Annual report
4:03pm
424B4
62ijsgj p7bdhlh
11 Aug 21
Prospectus supplement with pricing info
5:05pm
S-1/A
v0rc4y2x
2 Aug 21
IPO registration (amended)
6:08am
S-1/A
EX-3.4
idv8 g3scfoi1hwt51o
2 Aug 21
IPO registration (amended)
6:08am
S-1
6sfta 369k
16 Jul 21
IPO registration
5:02pm
DRS/A
1ffobxmgnt6eksc8185
12 Jul 21
Draft registration statement (amended)
12:00am
DRS/A
xsabiqazhm6vpd9t
21 Jun 21
Draft registration statement (amended)
12:00am
DRS
1ew k8ae9y
12 May 21
Draft registration statement
12:00am
- Prev
- 1
- Next